Alan Nurden: Highlighting the Role of Activated Platelets in Heart and Kidney Complications of Diabetes
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared a post on LinkedIn about a recent article by Nicolas Schommer et al, published in European Heart Journal:
“The mechanisms behind heart disease and kidney failure in patients with advanced stages of type I and type II diabetes remain incompletely defined. In this remarkable study, Schommer et al highlight roles for PAD4, neutrophil extracellular traps and inflammasome activation in these potentially fatal events.
The accumulation of platelets at sites of heart and kidney lesions is important not only for thrombosis but also as a source of the TGF-beta1 that drives renal fibrosis.
Whether activated platelets with surface expression of P-selectin and/or phosphatidylserine exposure (favoring thrombin generation) also help recruit neutrophils at the lesion sites also merits attention.
While recognizing past studies, the role of activated and procoagulant platelets (and derived microparticles) in diabetes merits further study.”
Title: Neutrophil extracellular traps and peptidylarginine deiminase 4–mediated inflammasome activation link diabetes to cardiorenal injury and heart failure
Authors: Nicolas Schommer, Nicolas Gendron, Krystin Krauel, Stijn Van Bruggen, Pierre-André Jarrot, Alexander Maier, William Chan, Harald F Langer, Daniel Duerschmied, Dirk Westermann, Karin Klingel, Denisa D Wagner, Lukas A Heger
Read the Full Article on European Heart Journal.
Other articles featuring Alan Nurden on Hemostasis Today.
-
Apr 15, 2026, 18:45Elias Lee: Acute PE from Subclavian VT – CT Scan Diagnosis, Radiology Interpretation, and Emergency Imaging Insights
-
Apr 15, 2026, 17:30Rivaroxaban versus Aspirin after Atrial Fibrillation Ablation – Cardiology Insights and Heart Health
-
Apr 15, 2026, 17:01Emmanuel J Favaloro: A Practical Approach to Inherited and Acquired Coagulation Disorders
-
Apr 15, 2026, 16:55Chokri Ben Lamine: VA-ECMO vs VV-ECMO Thromboembolic Events – Key Clinical Pearls
-
Apr 15, 2026, 16:54Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory
-
Apr 15, 2026, 16:53Sickle Cell Disease Care Varies by Region – ASH
-
Apr 15, 2026, 16:40Jorge Lima։ Understanding Recurrent Pregnancy Loss
-
Apr 15, 2026, 16:26Pregnancy-Induced Rise in FIX Activity – A Challenge to International Hemophilia Guidelines – JTH
-
Apr 15, 2026, 16:18Ken Checicki: How Restoring Blood Flow Can Solve Post – DVT Complications